The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Alcartis 15 mg orodispersible tablets



EGIS Pharmaceuticals PLCPA1470/005/007

Main Information

Trade NameAlcartis 15 mg orodispersible tablets
Active SubstancesAripiprazole
Dosage FormOrodispersible tablet
Licence HolderEGIS Pharmaceuticals PLC
Licence NumberPA1470/005/007

Group Information

ATC CodeN05AX Other antipsychotics
N05AX12 aripiprazole

Status

License statusWithdrawn
Withdrawn Date26/02/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0092-032-056
Interchangeable List DocumentPDF of Interchangeable List
« Back